| This is your first time coming to Nordic Life Science Days and our pre-event NLS Invest. What attracts you to the Nordics? – IPF Partners is the leading growth debt provider exclusively dedicated to the healthcare sector and mainly focusing on Europe. Our team identifies the Nordic region as a fast growing environment for life science and medical technology companies. Our investment story within the Nordics dates back to 2013 with an investment in Bone Support. The Nordic region has become over time one of our preferred area for deal origination. What are you looking for among the companies present? – As a lender, IPF Partners provides low to non-dilutive financing to fast-growing listed and private healthcare companies. We would like to meet medtech, biotech, diagnostic and digital health companies at late clinical or early commercial stage and looking for financing in order to speed up their commercial expansion. IPF provides debt investments in the range of €5-30M. Our type of financing solutions is of particular interest for companies expecting a major valuation inflection point in the near future and looking to raise non-dilutive funding before that to optimize their funding mix. |
Eléonore Maguin on NLSDays and NLSInvest
